← Back to Search

Flour Particle Size for Glycemic Response in Healthy Adults (PLO Trial)

N/A
Recruiting
Led By G. Harvey Anderson, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-45 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after treatment consumption.
Awards & highlights

PLO Trial Summary

This trial will compare the effects of different types of flour on blood sugar, amino acids, and how much people eat.

Who is the study for?
Healthy adults aged 18-45 with a BMI of 18.5-29.9, who eat breakfast regularly and can maintain their usual diet and exercise routine during the trial. Participants must not have significant health issues like gastrointestinal disorders, hypertension, or a history of major diseases such as cardiovascular disease or diabetes.Check my eligibility
What is being tested?
The study is testing how different sizes of pea, lentil, and oat flour in foods affect blood sugar levels after eating, feelings of hunger/fullness, food intake at the next meal, and amino acid release in healthy individuals.See study design
What are the potential side effects?
Since this trial involves common food ingredients (pea flour, lentil flour, oat flour), side effects are expected to be minimal but could include digestive discomfort if participants have unknown sensitivities to these foods.

PLO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 45 years old.

PLO Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline and at 15, 30, 45, 60, 90, 120, and 140 minutes after treatment consumption.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and at 15, 30, 45, 60, 90, 120, and 140 minutes after treatment consumption. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in postprandial glycemic response
Secondary outcome measures
Energy & fatigue
Food intake
Physical comfort
+3 more

PLO Trial Design

3Treatment groups
Experimental Treatment
Group I: PeaExperimental Treatment1 Intervention
Treatment 1: crackers made with 25% whole pea flour + 75% all-purpose wheat flour; Treatment 2: crackers made with 25% coarse pea flour + 75% all-purpose wheat flour; Treatment 3: crackers made with 25% fine pea flour + 75% all-purpose wheat flour; Treatment 4: crackers made with 100% all-purpose wheat flour (control)
Group II: OatsExperimental Treatment1 Intervention
Treatment 1: porridge made with whole oat flour; Treatment 2: porridge made with coarse oat flour; Treatment 3: porridge made with fine oat flour; Treatment 4: porridge made with commercial oat flour (control)
Group III: LentilExperimental Treatment1 Intervention
Treatment 1: crackers made with 25% whole lentil flour + 75% all-purpose wheat flour; Treatment 2: crackers made with 25% coarse lentil flour + 75% all-purpose wheat flour; Treatment 3: crackers made with 25% fine lentil flour + 75% all-purpose wheat flour; Treatment 4: crackers made with 100% all-purpose wheat flour (control)

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
690 Previous Clinical Trials
1,019,583 Total Patients Enrolled
6 Trials studying Malnutrition
9,410 Patients Enrolled for Malnutrition
Saskatchewan Food Industry Development CenterUNKNOWN
University of SaskatchewanOTHER
251 Previous Clinical Trials
154,350 Total Patients Enrolled

Media Library

Crackers made with whole, coarse, or fine lentil and/or wheat flour Clinical Trial Eligibility Overview. Trial Name: NCT05291351 — N/A
Malnutrition Research Study Groups: Lentil, Oats, Pea
Malnutrition Clinical Trial 2023: Crackers made with whole, coarse, or fine lentil and/or wheat flour Highlights & Side Effects. Trial Name: NCT05291351 — N/A
Crackers made with whole, coarse, or fine lentil and/or wheat flour 2023 Treatment Timeline for Medical Study. Trial Name: NCT05291351 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom is enrollment offered in this experiment?

"This medical experiment is seeking 60 people of ages 18-45 who suffer from obesity. To qualify, applicants must meet the following criteria: BMI between 18.5 and 29.9 kg/m2, abstinence from alcohol in the 24 hours prior to testing visits, maintaining their current diet and supplement use throughout the trial period, abstention from intense physical activity for a full day before attending test visits, understanding of study procedures with an expressed willingness to provide informed consent as well as authorization to release relevant protected health information to our team at Power."

Answered by AI

Is this trial inviting new participants to join?

"Clinicaltrials.gov shows that this research is actively recruiting patients, with the original posting on April 1st and the most recent update on May 26th of 2022."

Answered by AI

How many participants is the experiment currently involving?

"That is accurate. According to the information on clinicaltrials.gov, this medical trial which was published on April 1st 2022 is currently recruiting patients. A total of 60 individuals need to be recruited from one location specifically for this study."

Answered by AI

Are senior citizens being accepted into this experimental protocol?

"The criteria for participation in this trial necessitates that the patient be between 18 and 45 years of age."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Impact of Pea, Lentil and Oat Flour Particle Size on Glycemic Response in Healthy Adults
G. Harvey Anderson 2022. "Impact of Pea, Lentil and Oat Flour Particle Size on Glycemic Response in Healthy Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05291351.
~19 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top